Your browser doesn't support javascript.
loading
Function and structure of bradykinin receptor 2 for drug discovery.
Shen, Jin-Kang; Zhang, Hai-Tao.
Afiliação
  • Shen JK; Hangzhou Institute of Innovative Medicine, Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
  • Zhang HT; Hangzhou Institute of Innovative Medicine, Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. haitaozhang@zju.edu.cn.
Acta Pharmacol Sin ; 44(3): 489-498, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36075965
Type 2 bradykinin receptor (B2R) is an essential G protein-coupled receptor (GPCR) that regulates the cardiovascular system as a vasodepressor. Dysfunction of B2R is also closely related to cancers and hereditary angioedema (HAE). Although several B2R agonists and antagonists have been developed, icatibant is the only B2R antagonist clinically used for treating HAE. The recently determined structures of B2R have provided molecular insights into the functions and regulation of B2R, which shed light on structure-based drug design for the treatment of B2R-related diseases. In this review, we summarize the structure and function of B2R in relation to drug discovery and discuss future research directions to elucidate the remaining unknown functions of B2R dimerization.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor B2 da Bradicinina / Antagonistas de Receptor B2 da Bradicinina Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor B2 da Bradicinina / Antagonistas de Receptor B2 da Bradicinina Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article